All podcasts

Overcoming CAR-T Cell Bottlenecks - Dr. Andy Scherenberg

May 4, 2024 by Dr. Kevin Folta in Talking Biotech

Apple podcasts linkGoogle podcasts linkSpotify podcasts link

Immunotherapy is weaponizing the body's immune system against cancer or other disease. One of the most promising approaches is CAR-T cell therapy, yet as this technology has been implemented, it's limitations have been identified. Dr. Andy Schernberg described the current drawbacks of CAR-T cells and how his company, Umoja, is re-engineering CAR-T cells in vivo to create more effective therapies, including approaches that can address solid tumors. Co-hosted by Donald Coon. www.umoja-biopharma.com

Colabra

Get your whole lab on the same page today.

Learn more